About this research peptide
Tirzepatide is a dual GIP/GLP-1 receptor agonist studied in literature relevant to glycemic regulation and body-composition research. Investigators working on PMOS metabolic models and the broader metabolic-endocrine spectrum have referenced Tirzepatide as a comparator in published preclinical studies.
Researchers exploring conditions that disproportionately affect women — including autoimmune-driven inflammation, perimenopausal symptom mapping, hormonal-metabolic dysregulation, and post-surgical recovery in women’s-health procedures — have included this compound in their reference libraries.
This product is supplied as a lyophilized powder of ≥99% purity, with a lot-specific Certificate of Analysis available through the link in the Specifications tab.
Cited research
Cited research will be published on this product page as new literature is indexed. Citations are provided for research context only — inclusion does not imply any health claim or endorsement of personal use.








